Drug intelligence / Profile preview

s-metoprolol

Development stage
Phase 4
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

**s-Metoprolol** is the S-enantiomer of metoprolol, a selective beta-1 adrenergic receptor antagonist (beta-blocker). It operates by selectively blocking beta-1 adrenergic receptors in cardiac tissue, diminishing the effects of catecholamines (epinephrine and norepinephrine), which leads to a reduction in heart rate, myocardial contractility, cardiac output, and blood pressure. S-Metoprolol is more cardioselective and is the pharmacologically active isomer in racemic metoprolol formulations. Its primary indications are management of hypertension, angina pectoris, chronic heart failure, and post-myocardial infarction risk reduction[1][4][6].

Brand names
Toprol-XLMetoprolol Succinate ERKapspargo Sprinkle
Other names
s-metoprolol
02

Targets

ADRB1 (β1)ADRB2 (β2)

Beyond the preview

Go deeper on s-metoprolol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on s-metoprolol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call